US EditionPublished • loading... • Updated
"Cancers" Study on Cancer Risk Coordinated by Prof. Giordano - Sbarro Health Research Organization
Summary by SHRO
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
"Cancers" Study on Cancer Risk Coordinated by Prof. Giordano - Sbarro Health Research Organization
THE STUDY HIGHLIGHTS THAT CANCER RISK INCREASES IN AUTOIMMUNE DISEASES BUT DECREASES WITH ANTI-INFLAMMATORY THERAPIES In patients affected by immune-mediated inflammatory diseases (IMID), such as rheumatoid arthritis, systemic sclerosis, systemic lupus erythematosus, and other widespread connective tissue diseases, the risk of developing tumors is significantly higher in the early stages of the disease but tends to decrease progressively with th…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
